Work

A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas

Year: 2024

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2024.11.015

Authors: Nicole Foley, Peter A. Riedell, Nancy L. Bartlett, Amanda F. Cashen, Brad S. Kahl, Todd A. Fehniger, Anne Fischer, Chaz Moreno, Jingxia Liu, Kenneth R. Carson, Neha Mehta-Shah

Institutions: Washington University in St. Louis, University of Chicago, Northwestern University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Leukemia and Lymphoma Society

OpenAlex ID: W4404992553

FWCI: 0.786

Cites: 38

Cited by: 3

Related to: 10